rekrunner wrote:
I'm also not interested in his professional opinion, unless it is supported by data used to arrive at that opinion, and there is a discussion of potential confounders.
The fact is that Schumacher did not show that any performance improvement occurred. You even conceded that.
This should render the whole performance discussion moot.
Assuming there was any performance improvement at all, steroids, HGH, SARMs, etc. are always potential confounders regardless of the limited scope and purpose of the CAS arbitration.
Arguing that CAS did not consider these factors works against you. Do you honestly not understand that?
I'm not denying that steroids, HGH, SARMs, etc are used in conjunction with EPO/blood transfusions by dopers as part of their programs (nothing new there). However, in a CAS hearing or Disciplinary Tribunal for an ABP hematological-anomalies case, the arbitrators do not consider those PEDs as factors in the case. The athlete didn't test positive for any of those substances - it's irrelevant and not the issue at the hearing. The only issue before arbitrations is whether or not the IAAF can prove to the satisfaction of the arbitrator/DT panel that the athlete's abnormal blood values are the result of artificial means (ESA, blood transfusions, etc.) and not the result of a physiological or pathological reason. The council for the athlete will bring up defenses such as altitude training, sickness, mental stress, etc. as the cause of the anomalies. Other PED use as potential cofounders is never brought up by either the anti-doping experts nor the council for the athlete or even the arbitrator - it's not the issue at hand for ABP hematological-anomalies cases.
For someone who puts so much emphasis on evidence and expertise, I'm surprised you're not at all interested in the expert opinion of a world-renowned anti-doping expert, such as Schumacher, in these hearings (the arbitrators are very interested in his opinions). Schumacher, who has been the team physician for the German Olympic team since 2000, and a senior member of the IAAF's anti-doping expert panel should know a little something about elevated blood levels and the relationship with performance enhancement...don't you think?
Listen to what he says in the Ugarova CAS (2016/0/4463), paragraph 103:
- 103. "In addition, importantly, the Sole Arbitrator notes that Sample 2 was taken on the eve of an important competition (i.e. the European Championship in Helsinki), whereas Sample 3, 4 and 5 were not taken in temporal vicinity to a competition. As testified by Dr. Schumacher, high HGB values enhance sporting performance. The Sole Arbitrator therefore finds that the coincidence of the fact that Sample 2 contained high HGB values, whereas Sample 3, 4 and 5 contained no such high levels, makes it indeed highly likely that the abnormal blood values in Sample 2 are to be explained by the use of prohibited substances or prohibited methods."
Sample 2 was on the eve of the 2012 EC where Ugarova made the finals of the 1500.
The values from sample 2 taken on June 26 were 16.5 Hgb (49.5 Hct) and a corresponding Off-score of 141.00 (99.99 specificity).
This from the Arbitrator - paragraph 141:
- 141. "The Sole Arbitrator does not deem it appropriate to entirely dispose of any disqualification of results as he is convinced that the Athlete doped and because the main purpose of disqualification of results is not to punish the transgressor, but rather to correct any unfair advantage and remove any tainted performances from the record LEWIS / TAYLOR (Eds.), Sport: Law and Practice, 2014, para. C.162, with further references). The Sole Arbitrator, considering that neither a doping scheme, nor a doping plan has been established in the present case, deems it adequate and proportionate, comparing to other cases where a single anti-doping rule violation could have been established through the analysis of a positive sample, to disqualify the results of the Athlete for a period of six months. Six months seem to be a period long enough for an anti-doping organization to perform results management including a possible disciplinary proceeding."
"Unfair advantage" & "tainted performances" as a result of elevated blood values from doping. Ugarova's 8th place finish in the final was annulled.
So, perhaps you're confused and think elevated blood values from altitude training is performance enhancing (e.g., Stray-Gundersen) but not elevated blood values from doping.